400 related articles for article (PubMed ID: 35255803)
1. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
2. Targeting Mitochondrial Complex I Deficiency in MPP
Li H; Zhang J; Shen Y; Ye Y; Jiang Q; Chen L; Sun B; Chen Z; Shen L; Fang H; Yang J; Gu H
Biol Proced Online; 2024 Apr; 26(1):9. PubMed ID: 38594619
[TBL] [Abstract][Full Text] [Related]
3. In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Matsuno-Yagi A; Yagi T
J Biol Chem; 2006 May; 281(20):14250-5. PubMed ID: 16543240
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Yeast NADH Dehydrogenase (Ndi1) Expression on Mitochondrial Function and Inclusion Formation in a Cell Culture Model of Sporadic Parkinson's Disease.
Cronin-Furman EN; Barber-Singh J; Bergquist KE; Yagi T; Trimmer PA
Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934776
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.
Barber-Singh J; Seo BB; Nakamaru-Ogiso E; Lau YS; Matsuno-Yagi A; Yagi T
Rejuvenation Res; 2009 Aug; 12(4):259-67. PubMed ID: 19653878
[TBL] [Abstract][Full Text] [Related]
6. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.
Marella M; Seo BB; Nakamaru-Ogiso E; Greenamyre JT; Matsuno-Yagi A; Yagi T
PLoS One; 2008 Jan; 3(1):e1433. PubMed ID: 18197244
[TBL] [Abstract][Full Text] [Related]
7. Xenotransplantation of mitochondrial electron transfer enzyme, Ndi1, in myocardial reperfusion injury.
Perry CN; Huang C; Liu W; Magee N; Carreira RS; Gottlieb RA
PLoS One; 2011 Feb; 6(2):e16288. PubMed ID: 21339825
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for complex I deficiencies.
Seo BB; Nakamaru-Ogiso E; Cruz P; Flotte TR; Yagi T; Matsuno-Yagi A
Hum Gene Ther; 2004 Sep; 15(9):887-95. PubMed ID: 15353043
[TBL] [Abstract][Full Text] [Related]
9. Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Kao MC; Matsuno-Yagi A
Rejuvenation Res; 2006; 9(2):191-7. PubMed ID: 16706641
[TBL] [Abstract][Full Text] [Related]
10. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
[TBL] [Abstract][Full Text] [Related]
11. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
[TBL] [Abstract][Full Text] [Related]
12. Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson's disease.
Goyani S; Shinde A; Shukla S; Saranga MV; Currim F; Mane M; Singh J; Roy M; Gohel D; Chandak N; Vasiyani H; Singh R
FEBS J; 2024 Jun; 291(12):2636-2655. PubMed ID: 38317520
[TBL] [Abstract][Full Text] [Related]
13. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells.
Seo BB; Kitajima-Ihara T; Chan EK; Scheffler IE; Matsuno-Yagi A; Yagi T
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9167-71. PubMed ID: 9689052
[TBL] [Abstract][Full Text] [Related]
14. Possibility of transkingdom gene therapy for complex I diseases.
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Matsuno-Yagi A
Biochim Biophys Acta; 2006; 1757(5-6):708-14. PubMed ID: 16581014
[TBL] [Abstract][Full Text] [Related]
15. A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Yagi T; Matsuno-Yagi A
Mol Ther; 2002 Sep; 6(3):336-41. PubMed ID: 12231169
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae.
Seo BB; Matsuno-Yagi A; Yagi T
Biochim Biophys Acta; 1999 May; 1412(1):56-65. PubMed ID: 10354494
[TBL] [Abstract][Full Text] [Related]
17. The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I.
Seo BB; Marella M; Yagi T; Matsuno-Yagi A
FEBS Lett; 2006 Nov; 580(26):6105-8. PubMed ID: 17055488
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Neuronal CoQ
Millichap L; Turton N; Damiani E; Marcheggiani F; Orlando P; Silvestri S; Tiano L; Hargreaves IP
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928331
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.
Marella M; Seo BB; Yagi T; Matsuno-Yagi A
J Bioenerg Biomembr; 2009 Dec; 41(6):493-7. PubMed ID: 19904590
[TBL] [Abstract][Full Text] [Related]
20. Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells.
Seo BB; Wang J; Flotte TR; Yagi T; Matsuno-Yagi A
J Biol Chem; 2000 Dec; 275(48):37774-8. PubMed ID: 10982813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
